Does LISINOPRIL Cause Excessive granulation tissue? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Excessive granulation tissue have been filed in association with LISINOPRIL (Lisinopril). This represents 0.0% of all adverse event reports for LISINOPRIL.
7
Reports of Excessive granulation tissue with LISINOPRIL
0.0%
of all LISINOPRIL reports
0
Deaths
3
Hospitalizations
How Dangerous Is Excessive granulation tissue From LISINOPRIL?
Of the 7 reports, 3 (42.9%) required hospitalization.
Is Excessive granulation tissue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISINOPRIL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does LISINOPRIL Cause?
Angioedema (5,370)
Drug hypersensitivity (3,779)
Cough (2,527)
Completed suicide (2,246)
Drug ineffective (2,208)
Acute kidney injury (2,022)
Dyspnoea (1,856)
Dizziness (1,758)
Hypotension (1,750)
Fatigue (1,549)
What Other Drugs Cause Excessive granulation tissue?
CARBIDOPA\LEVODOPA (117)
ADALIMUMAB (38)
BACLOFEN (31)
ZOLEDRONIC ACID (29)
ZOMETA (27)
AREDIA (21)
METHOTREXATE (19)
RITUXIMAB (13)
BECAPLERMIN (11)
PAMIDRONATE (11)
Which LISINOPRIL Alternatives Have Lower Excessive granulation tissue Risk?
LISINOPRIL vs LISOCABTAGENE MARALEUCEL
LISINOPRIL vs LITHIUM
LISINOPRIL vs LIXISENATIDE
LISINOPRIL vs LOBAPLATIN
LISINOPRIL vs LOFEXIDINE